Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
9.05
0.10 (1.12%)
At close: Aug 15, 2025, 3:59 PM
9.24
2.10%
After-hours: Aug 15, 2025, 07:50 PM EDT
Avalo Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 441K | 441K | 441K | 820K | 807K | 1.45M | 1.93M | 2.25M | 16.96M | 17.35M | 18.05M | 17.37M | 3.77M | 6.1M | 5.4M | 6.67M | 6.43M | 4.42M |
Cost of Revenue | -493K | -284K | -364K | -672K | 289K | 654K | 1.28M | 2.13M | 2.41M | 3.27M | 3.44M | 3.24M | 3.62M | 2.13M | 1.49M | 1.15M | 316.06K | 310.64K |
Gross Profit | 934K | 725K | 805K | 1.49M | 518K | 796K | 640K | 124K | 14.56M | 14.09M | 14.62M | 14.13M | 156K | 3.96M | 3.9M | 5.53M | 6.12M | 4.11M |
Operating Income | -60.16M | -50.42M | -68.51M | -58.95M | -49.84M | -47.42M | -23.44M | -28.55M | -21.6M | -26.28M | -38.34M | -49.88M | -69.54M | -74.84M | -84.57M | -80.51M | -77.32M | -72.01M |
Interest Income | 2.25M | 1.15M | 100K | 100K | 100K | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17K | 17K | 17K | 25.71K |
Pretax Income | -46.09M | 73.13M | -35.02M | -7.97M | -36.21M | -142.87M | -31.53M | -33.16M | -24.74M | -29.54M | -41.63M | -50.97M | -71.63M | -76.03M | -84.55M | -81.73M | -77.52M | -73.43M |
Net Income | -46.22M | 73.01M | -35.13M | -7.96M | -36.22M | -142.88M | -31.54M | -33.19M | -24.77M | -29.56M | -41.66M | -51.04M | -71.63M | -75.75M | -84.38M | -80.82M | -76.89M | -73.06M |
Selling & General & Admin | 20.17M | 19.59M | 17.24M | 14.68M | 12.89M | 10.79M | 10.3M | 10.58M | 11.38M | 11.73M | 20.71M | 23.73M | 26.38M | 31M | 24.66M | 23.29M | 22.4M | 21.75M |
Research & Development | 40.92M | 31.55M | 52.08M | 45.76M | 37.47M | 37.43M | 13.78M | 18.09M | 23.88M | 27.73M | 31.31M | 36.65M | 40.16M | 44.21M | 59.84M | 60.96M | 59.28M | 52.63M |
Other Expenses | n/a | n/a | n/a | n/a | -17K | -17K | -43K | -43K | -26K | -26K | 38K | 305K | 290K | 285K | 671K | 366.96K | 400.62K | 801.42K |
Operating Expenses | 61.09M | 51.14M | 69.32M | 60.45M | 50.36M | 48.21M | 24.08M | 28.67M | 35.26M | 39.47M | 52.06M | 60.68M | 67.26M | 76.37M | 86.04M | 86.04M | 83.44M | 76.12M |
Interest Expense | n/a | n/a | n/a | n/a | 1.55M | 2.55M | 3.5M | 4.45M | 3.79M | 3.95M | 4.17M | 4.41M | 4.49M | 3.58M | 2.41M | 1.22M | 239K | 8.71K |
Selling & Marketing Expenses | 801K | 822K | 817K | 35K | 35K | 21K | 27K | 32K | 32K | 39K | 1.95M | 2.81M | 3.55M | 4.32M | 2.83M | 2.51M | 2.23M | 2.1M |
Cost & Expenses | 60.6M | 50.86M | 68.95M | 59.77M | 50.65M | 48.87M | 25.37M | 30.8M | 37.66M | 42.73M | 55.49M | 63.92M | 70.88M | 78.5M | 87.53M | 87.19M | 83.76M | 76.43M |
Income Tax Expense | 124K | 115K | 114K | -9K | 13K | 13K | 14K | 31K | 28K | 26K | 27K | 3K | 6K | -198K | -196K | -365.43K | -370.15K | -625.11K |
Shares Outstanding (Basic) | 10.83M | 10.51M | 10.47M | 8.13M | 7.65M | 859.38K | 801.75K | 194.85K | 58.22K | 48.84K | 39.25K | 39.22K | 39.17K | 39.16K | 39.63K | 34.89K | 37.71K | 32.94K |
Shares Outstanding (Diluted) | 10.83M | 10.51M | 10.47M | 10.78M | 7.65M | 859.38K | 801.75K | 194.85K | 58.22K | 48.84K | 39.25K | 39.22K | 39.17K | 39.16K | 39.63K | 34.89K | 37.71K | 32.94K |
EPS (Basic) | 13.55 | 110.68 | -29.21 | -53.29 | -82.95 | -318.89 | -381.56 | -621.36 | -513.15 | -703.97 | -1.06K | -1.3K | -1.88K | -2K | -2.37K | -2.44K | -2.42K | -2.52K |
EPS (Diluted) | 9.44 | 24.23 | -115.66 | -136.32 | -165.29 | -318.89 | -381.56 | -621.36 | -513.15 | -703.97 | -1.06K | -1.3K | -1.88K | -2K | -2.37K | -2.44K | -2.42K | -2.52K |
EBITDA | -61.22M | -50.15M | -68.34M | -63.32M | -54.2M | -51.77M | -28M | -28.6M | -20.77M | -25.45M | -37.3M | -46.14M | -66.3M | -71.17M | -80.5M | -78.62M | -75.43M | -70.14M |
EBIT | -61.59M | -50.42M | -68.51M | -63.46M | -54.35M | -51.92M | -28.16M | -28.75M | -20.91M | -25.59M | -37.46M | -46.57M | -67.14M | -72.45M | -82.16M | -80.53M | -77.31M | -71.99M |
Depreciation & Amortization | 371K | 270K | 169K | 144K | 151K | 159K | 158K | 150K | 143K | 132K | 166K | 426K | 847K | 1.27M | 1.66M | 1.9M | 1.87M | 1.84M |